Held on 21 June 2017
Medicamen Biotech announced that the Board of Directors at its meeting held on 21 June 2017 has approved the following -Approval to the Issue & Allot 306000 Warrants, convertible into Equity Shares of the Company at a price of Rs. 543/- per warrant (including a premium of Rs.533/- each), in accordance with the SEBI (ICDR) Regulations, 2009 on Preferential Allotment basis to a promoter group and non promoter group/ Investors.
Calling of an Extraordinary General Meeting, of the Company in relation to the Preferential Issue as aforesaid on 17 July, 2017.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
